Project Grant R01DE033676

Award Date 9/12/24
Completion Date 8/31/29
Dollars Obligated $347K
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75246, USA
Similar Awards
This $1,849,232.90 Project Grant was awarded by the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121), to The General Hospital Corporation (Massachusetts General Hospital) to identify the cellular and molecular identity of genes and pathways defining dental mesenchymal cell differentiation and fate early in tooth development. The goal is to leverage this information to develop potential therapeutics,...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $2,055,996 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to the University of Texas Health Science Center at Houston. The grant, awarded on September 20, 2024, will fund a research program to investigate skeletal stem cell plasticity as a central mechanism in craniofacial bone formation and diseases. The program consists of three main components: 1) Examining the fates and...
The National Institute of Dental and Craniofacial Research (NIDCR) has awarded a $557,606 Project Grant under the Oral Diseases and Disorders Research (CFDA 93.121) program to President and Fellows of Harvard College, doing business as Harvard Medical School. The grant, with a period of performance from April 16, 2025 to March 31, 2030, will support research to characterize periodontal crestal stem cells (PCSCs) and elucidate the signaling pathways that regulate PCSC activation and...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $157,500 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to The Ohio State University to conduct research on the cellular mechanisms regulating tooth development. The research aims to determine how the signaling molecule SEMA7A influences the mineralization of dentin, elongation of tooth roots, and innervation of teeth. The study will use global and conditional SEMA7A knockout mouse...
This $658,750 Project Grant was awarded by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The grant will fund research to explore the function of novel arginine phosphorylation in the physiology of Streptococcus bacteria, a medically important genus. The primary goals are to understand the role of arginine phosphorylation in the dental pathogen Streptococcus mutans and identify the enzyme responsible for...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $421,800 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to Midwestern University. The purpose of this 3-year grant, with a start date of September 7, 2023, is to develop hybrid hydrogel-based dental adhesives that are less vulnerable to hydrolytic degradation compared to current methacrylate-based alternatives. The goal is to create a truly biomimetic dental adhesive that can not only...
This federal Project Grant award, totaling $476,287, was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The grant supports research to investigate the role of the MERTK receptor tyrosine kinase in regulating alveolar bone regeneration following tooth extraction. The primary objectives are to: 1) Determine the effects of MERTK signaling on resident alveolar bone stem cells that contribute to...
This $582,000 federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research (CFDA 93.121) program, will support research to investigate the use of epigenetic modulators to reverse the effects of peri-implantitis. The University of Rochester will conduct this 5-year research project, which aims to understand the inflammatory and oxidative stress mechanisms that contribute to peri-implantitis, a common...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $185,918 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to Brigham & Women's Hospital Inc. in Boston, Massachusetts. The grant, effective from February 1, 2025 to January 31, 2027, will evaluate the impact of Medicaid coverage for treatment of periodontal disease on oral health outcomes, emergency department use, healthcare costs, and complications of diabetes among Medicaid...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $443,576 to the University of Washington to develop bioengineered 3D tooth germs for tooth regeneration research. The key objectives are to: 1) investigate how biomaterial composition and mechanical properties regulate stem cell renewal and support long-term growth of odontogenic epithelial stem cells and neural...

The federal Project Grant award R01DE033676, totaling $346,938.00, was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121). The grant supports research to understand how a novel GTPase regulator, known as DIN, governs the regenerative capacity of mesenchymal stem cells (MSCs) in murine teeth. The research aims to determine DIN's role in regulating MSC homeostasis during tissue turnover and injury healing processes, as well as how DIN interacts with the RhoA and Rac1 GTPases and their downstream signaling pathways, including the canonical Wnt pathway. The grant was awarded to the Texas A&M University System Health Science Center, a U.S. state government entity and educational institution, and the project is scheduled for completion by August 31, 2029.

Generated 7/1/25, 1:50 AM